PT Diagnos Laboratorium Utama Tbk (IDX:DGNS)

Indonesia flag Indonesia · Delayed Price · Currency is IDR
171.00
-14.00 (-7.57%)
Apr 24, 2025, 4:09 PM WIB
-47.87%
Market Cap 231.25B
Revenue (ttm) 163.07B
Net Income (ttm) 747.44M
Shares Out 1.25B
EPS (ttm) 0.60
PE Ratio 309.39
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 47,898,800
Average Volume 11,828,820
Open 190.00
Previous Close 185.00
Day's Range 170.00 - 208.00
52-Week Range 121.00 - 380.00
Beta 0.48
RSI 66.87
Earnings Date May 28, 2025

About IDX:DGNS

PT Diagnos Laboratorium Utama Tbk provides health services using laboratories in Indonesia. The company offers clinical pathology laboratory tests comprising hematology, hemostasis, clinical chemistry, urinalysis, biomolecular, immunology, microbiology, and anatomical pathology; and genomics laboratory tests that provides genetic testing for reproductive health, pregnant women, couples who want to have a child, oncology tests, drug sensitivity, DNAandMe, and others. It also offers homecare health services for hemoglobin, ferritin, retilulosit, ... [Read more]

Sector Healthcare
Founded 2007
Employees 96
Stock Exchange Indonesia Stock Exchange
Ticker Symbol DGNS
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.